Neuphoria Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NEUP and other ETFs, options, and stocks.About NEUP
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor.
NEUP Key Statistics
Stock Snapshot
Neuphoria Therapeutics Inc.(NEUP) stock is priced at $4.32, giving the company a market capitalization of 24.15M. It carries a P/E multiple of -0.18.
During the trading session on 2026-03-07, Neuphoria Therapeutics Inc.(NEUP) shares reached a daily high of $4.64 and a low of $4.32. At a current price of $4.32, the stock is 0.0% higher than the low and still -6.8% under the high.
Trading activity shows a volume of 71.22K, compared to an average daily volume of 58.15K.
The stock's 52-week range extends from a low of $3.65 to a high of $21.40.
The stock's 52-week range extends from a low of $3.65 to a high of $21.40.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.